Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
Clinical trial NCT06045975 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06045975
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2027-09-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.